Multifocal Motor Neuropathy
Neurology
2
Pipeline Programs
2
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
argenxBelgium - Zwijnaarde
2 programs1
ARGX-117Phase 21 trial
A Prospective Longitudinal Study in Adults With Multifocal Motor NeuropathyN/A1 trial
Active Trials
DT
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
2027
2028
Dianthus TherapeuticsDNTH103
argenxARGX-117
argenxA Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy
Clinical Trials (3)
Total enrollment: 467 patients across 3 trials
A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy
Start: Sep 2024Est. completion: Mar 2028
Phase 2Recruiting
A Clinical Trial to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics and Immunogenicity of 2 Dose Regimens of ARGX-117 in Adults with Multifocal Motor Neuropathy
Start: Mar 2022Est. completion: Jun 202454 patients
Phase 2Completed
A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy
Start: Nov 2023Est. completion: Dec 2028413 patients
N/AActive Not Recruiting
Related Jobs in Neurology
Director, Distribution & Services
Xenon Pharmaceuticals
Remote
8h ago
Senior Medical Science Liaison (NYC Tri-State)
Xenon Pharmaceuticals
Remote
8h ago
$208K - $234K/yr
Director of Medical Affairs
CoMind
Miami, FL
9h ago
Director of Finance
CoMind
London, UK
9h ago
Electronics Engineering Manager
CoMind
London, UK
9h ago
Director of Information Technology
Zavation Medical Products
9h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 467 patients
2 companies competing in this space